Longevity Pulse
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
TutorialsClinical TutorialsVideosContinuous Listen
Free Subscription
Sign In
Deep Dive Audio
PAD2 vs PAD4 Enzyme Selectivity Mapped Across 256 PeptidesLongevity & Aging

PAD2 vs PAD4 Enzyme Selectivity Mapped Across 256 Peptides

Researchers systematically mapped how PAD2 and PAD4 enzymes citrullinate arginine residues by synthesizing 256 combinatorial peptides and analyzing them with advanced mass spectrometry. PAD2 proved broadly active, efficiently modifying 233 of 256 peptides, while PAD4 was far more selective, with flanking amino acids dramatically affecting activity. Proline at the C-terminal position strongly blocked citrullination for both enzymes, while asparagine at either flanking position enhanced it. These findings clarify the distinct substrate rules governing each enzyme and highlight a critical analytical challenge: asparagine-enhanced citrullination can be confused with asparagine deamidation, a common source of false positives in proteomics studies.

0:00--:--
Read Full Article
Longevity Pulse

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

Enter your email to subscribe:

© 2026 Longevity Pulse. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Pulse is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.